APA (7th ed.) Citation

S, X., R, Z., C, W., X, W., Y, T., L, D., . . . L, C. (2026). Functional xenogeneic hematopoietic cells maintaining donor-dominant identity and immune tolerance enable therapy. Experimental hematology & oncology, 15(1), . https://doi.org/10.1186/s40164-026-00767-3

Chicago Style (17th ed.) Citation

S, Xiong, et al. "Functional Xenogeneic Hematopoietic Cells Maintaining Donor-dominant Identity and Immune Tolerance Enable Therapy." Experimental Hematology & Oncology 15, no. 1 (2026). https://doi.org/10.1186/s40164-026-00767-3.

MLA (9th ed.) Citation

S, Xiong, et al. "Functional Xenogeneic Hematopoietic Cells Maintaining Donor-dominant Identity and Immune Tolerance Enable Therapy." Experimental Hematology & Oncology, vol. 15, no. 1, 2026, https://doi.org/10.1186/s40164-026-00767-3.

Warning: These citations may not always be 100% accurate.